Improving brain tumor imaging with a new MRI protocol
Establishing the clinical utility of a consensus DSC-MRI Protocol
['FUNDING_R01'] · UNIVERSITY OF TX MD ANDERSON CAN CTR · NIH-11082303
This study is working to make brain scans more accurate and helpful for people with brain tumors by creating better guidelines for doctors to follow, so patients can get clearer information about their tumors and treatment options.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF TX MD ANDERSON CAN CTR (nih funded) |
| Locations | 1 site (HOUSTON, UNITED STATES) |
| Trial ID | NIH-11082303 on ClinicalTrials.gov |
What this research studies
This research focuses on enhancing the clinical utility of dynamic susceptibility contrast (DSC) MRI for brain tumor imaging. By establishing best practice recommendations for this widely used imaging technique, the study aims to improve the accuracy and consistency of brain tumor assessments across multiple medical institutions. The research will involve validating a consensus protocol that can differentiate glioma grades, identify tumor components, and predict treatment responses. Patients undergoing brain tumor evaluations may benefit from more reliable imaging results and treatment decisions.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with gliomas or other brain tumors who require imaging assessments.
Not a fit: Patients with non-neoplastic brain conditions or those not undergoing imaging for brain tumors may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate diagnoses and better treatment planning for patients with brain tumors.
How similar studies have performed: Previous research has shown that standardized imaging protocols can significantly improve diagnostic accuracy in neuro-oncology, indicating a promising potential for this approach.
Where this research is happening
HOUSTON, UNITED STATES
- UNIVERSITY OF TX MD ANDERSON CAN CTR — HOUSTON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: QUARLES, CHRISTOPHER CHAD — UNIVERSITY OF TX MD ANDERSON CAN CTR
- Study coordinator: QUARLES, CHRISTOPHER CHAD
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.